Benitec Biopharma Inc Stock
Benitec Biopharma Inc Stock price
Key metrics
| Market capitalization | $211.62m |
| Enterprise Value | $143.92m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | 2.98 |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-22.41m |
| Cash position | $50.93m |
| EPS (TTM) EPS | $-5.28 |
Is Benitec Biopharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Benitec Biopharma Inc Stock Analysis
Analyst Opinions
5 Analysts have issued a Benitec Biopharma Inc forecast:
Analyst Opinions
5 Analysts have issued a Benitec Biopharma Inc forecast:
Financial data from Benitec Biopharma Inc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -22 -22 |
9%
9%
|
| Net Profit | -21 -21 |
2%
2%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Benitec Biopharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Benitec Biopharma Inc Stock News
Company Profile
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on April 13, 2020 and is headquartered in Hayward, CA.
| Head office | United States |
| CEO | Jerel Banks |
| Employees | 16 |
| Founded | 2019 |
| Website | www.benitec.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
